The BMJ investigates dispute over US group’s involvement in WHO’s trans health guideline

Guideline panel links to World Professional Association for Transgender Health (WPATH) raise questions about bias The World Health Organization (WHO) says that it is adhering to standard protocol in pursuing its transgender health guideline, but the process has been criticised for lacking transparency and an association with WPATH - an ...

2024-11-04T16:22:59+00:0031 October 2024|Press release, The BMJ|

Investigation finds “unexplained” millions in drug industry payments to the NHS

Many trusts didn’t recognise or couldn’t verify the payments Findings raise important questions about unrecognised conflicts of interest Pharmaceutical companies have paid an estimated £156 million to NHS trusts in England between 2015 and 2022 without the public being told what the payments are for, reveals an investigation by The BMJ today. ...

2024-10-24T11:26:41+00:0024 October 2024|Press release, The BMJ|

Gene signature shows promise to improve survival for breast cancer patients

First trial to show feasibility of gene signature to tailor treatment for high risk patients  Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today. Triple negative breast ...

2024-10-24T11:23:53+00:0024 October 2024|Press release, The BMJ|

Strong leadership and collaboration needed to tackle chronic diseases in China

Special collection lays out progresses and challenges in chronic disease prevention and control in China Today, The BMJ is launching a special collection of articles on tackling non-communicable diseases (NCDs) in China, such as cardiovascular and chronic respiratory diseases, cancer, and diabetes, which account for 91% of all deaths in China. The articles, written ...

2024-11-04T16:18:37+00:0018 October 2024|Corporate announcement, Partnership, The BMJ|
Go to Top